Gasbarrini A - Search Results

1

Primary Biliary Cholangitis: advances in management and treatment of the disease.

Invernizzi P, Floreani A, Carbone M, Marzioni M, Craxi A, Muratori L, Vespasiani Gentilucci U, Gardini I, Gasbarrini A, Kruger P, Mennini FS, Ronco V, Lanati E, Canonico PL, Alvaro D. Invernizzi P, et al. Among authors: gasbarrini a. Dig Liver Dis. 2017 Aug;49(8):841-846. doi: 10.1016/j.dld.2017.05.001. Epub 2017 May 8. Dig Liver Dis. 2017. PMID: 28546061 Free article.

2

Sacroileitis and peripheral arthropathy associated with ulcerative colitis: effect of infliximab on both articular and intestinal symptoms.

Lupascu A, Armuzzi A, De Pascalis B, Carloni E, Lauritano EC, Gasbarrini A, Pola P, Gasbarrini A. Lupascu A, et al. Among authors: gasbarrini a. Dig Liver Dis. 2004 Jun;36(6):423-5. doi: 10.1016/j.dld.2003.10.021. Dig Liver Dis. 2004. PMID: 15248384

3

CD133+ stem cell mobilization after partial hepatectomy depends on resection extent and underlying disease.

Zocco MA, Piscaglia AC, Giuliante F, Arena V, Novi M, Rinninella E, Tortora A, Rumi C, Nuzzo G, Vecchio FM, Bombardieri G, Gasbarrini A. Zocco MA, et al. Among authors: gasbarrini a. Dig Liver Dis. 2011 Feb;43(2):147-54. doi: 10.1016/j.dld.2010.06.008. Epub 2010 Aug 4. Dig Liver Dis. 2011. PMID: 20688587

4

Different Antibiotic No Culture Eradicating (DANCE) strategy: an easy way to manage H. pylori eradication.

Roccarina D, Franceschi F, Zocco MA, Garcovich M, Gasbarrini G, Gasbarrini A. Roccarina D, et al. Among authors: gasbarrini a, gasbarrini g. Dig Liver Dis. 2012 Nov;44(11):889-92. doi: 10.1016/j.dld.2012.05.010. Epub 2012 Jun 27. Dig Liver Dis. 2012. PMID: 22743557

5

Cost-effectiveness of sofosbuvir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, Gasbarrini A, Craxì A, Cammà C; WEF Study Group. Petta S, et al. Among authors: gasbarrini a. Hepatology. 2014 May;59(5):1692-705. doi: 10.1002/hep.27010. Epub 2014 Apr 1. Hepatology. 2014. PMID: 24691835

6

Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy.

Mennini FS, Marcellusi A, Andreoni M, Gasbarrini A, Salomone S, Craxì A. Mennini FS, et al. Among authors: gasbarrini a. Clinicoecon Outcomes Res. 2014 Jun 19;6:303-10. doi: 10.2147/CEOR.S62092. eCollection 2014. Clinicoecon Outcomes Res. 2014. PMID: 24971024 Free PMC article.

7

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C.

Petta S, Cabibbo G, Enea M, Macaluso FS, Plaia A, Bruno R, Gasbarrini A, Bruno S, Craxì A, Cammà C; WEF study group. Petta S, et al. Among authors: gasbarrini a. Dig Liver Dis. 2014 Oct;46(10):936-42. doi: 10.1016/j.dld.2014.06.009. Epub 2014 Jul 23. Dig Liver Dis. 2014. PMID: 25066806

8

Ethical assessment of hepatitis C virus treatment: The lesson from first generation protease inhibitors.

Sacchini D, Craxì L, Refolo P, Minacori R, Cicchetti A, Gasbarrini A, Cammà C, Spagnolo AG; WEF Study Group. Sacchini D, et al. Among authors: gasbarrini a. Dig Liver Dis. 2015 May;47(5):351-5. doi: 10.1016/j.dld.2014.11.011. Epub 2014 Nov 24. Dig Liver Dis. 2015. PMID: 25534233 Review.

9

Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study.

Petta S, Marzioni M, Russo P, Aghemo A, Alberti A, Ascione A, Antinori A, Bruno R, Bruno S, Chirianni A, Gaeta GB, Giannini EG, Merli M, Messina V, Montilla S, Perno CF, Puoti M, Raimondo G, Rendina M, Silberstein FC, Villa E, Zignego AL, Pani L, Craxì A; ABACUS study group; AIFA team. Petta S, et al. Lancet Gastroenterol Hepatol. 2017 Jun;2(6):427-434. doi: 10.1016/S2468-1253(17)30048-1. Epub 2017 Apr 10. Lancet Gastroenterol Hepatol. 2017. PMID: 28497758

10

Therapy experiences and preferences among patients with anemia: Results of a cross-sectional survey among Italian patients with inflammatory bowel disease.

Milovanovic S, Scaldaferri F, Canarecci S, Kheiraoui F, Ciancarella G, de Waure C, Collamati A, Schiavoni E, Gasbarrini A, Boccia S, Poscia A. Milovanovic S, et al. Among authors: gasbarrini a. Dig Liver Dis. 2017 Oct;49(10):1098-1103. doi: 10.1016/j.dld.2017.06.015. Epub 2017 Jul 5. Dig Liver Dis. 2017. PMID: 28778820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,725 results

Search Page